Mental Health Research

MedicalResearch.com eInterview with: Linden Oliver, MA, Clinical Research Coordinator University of Pennsylvania Behavioral Sleep Medicine Research Program Philadelphia, Pa MedicalResearch.com: What are the main findings of the study? Answer: We found that less sleep is associated with greater suicide risk in those with insomnia. Specifically, we looked at suicide risk in people with insomnia, and also asked how much sleep they got in the past month. In those with some suicide risk, the likelihood of being high risk (versus low risk) decreased by 72% for every hour of sleep that person reported getting at night.

Medical Research.com eInterview with: Prof. Jean Decety PhD Irving B. Harris Professor of Psychology and Psychiatry The University of Chicago 5848 S. University Ave. Chicago, IL 60637 - USA SCNL Web page: www.scnl.org Child NeuroSuite: www.childneurosuite.org MedicalResearch.com: What are the main findings of the study? Dr. Decety: In our study, psychopaths exhibited significantly less activation in the ventromedial prefrontal cortex, lateral orbitofrontal cortex, and brainstem relative to controls, but surprisingly showed greater activation in the insula.  The major difference in brain response between psychopaths compared to controls during the perception of others in pain was the lack of engagement of regions in the brainstem, orbitofrontal cortex (OFC) and ventromedial prefrontal cortex (vmPFC).

MedicalResearch.com eInterview with Dr. David Perry UCSF School of Medicine Clinical Fellow in Neurology 675 Nelson Rising Lane San Francisco CA 94158 MedicalResearch.com: What are the main findings of the study? Dr. Perry: We described two patients with clinical syndromes and brain imaging patterns that are consistent with Alzheimer’s disease. Both were found to have mutations in GRN, which are typically associated with inherited frontotemporal dementia. They both showed evidence of underlying Alzheimer’s pathology, in one case through autopsy confirmation (demonstrating Alzheimer’s disease in addition to TDP-43 pathology), and in the other case from a positive amyloid PET scan.

MedicalResearch.com: eInterview with Siran M. Koroukian, Ph.D. Population Health and Outcomes Research Core, Clinical & Translational Science Collaborative Associate Professor Department of Epidemiology and Biostatistics School of Medicine Case Western Reserve University Cleveland, OH 44106-7281 MedicalResearch.com: What are the main findings of the study? Dr. Koroukian: Among individuals who died of cancer, those with mental illness (MI) died an average of 10 years earlier than those without MI. Overall, there was excess mortality from cancer associated with having mental illness in all the race/sex strata: SMR, 2.16 (95% CI, 1.85-2.50) for black men; 2.63 (2.31-2.98) for black women; 3.89 (3.61-4.19) for nonblack men; and 3.34 (3.13-3.57) for nonblack women. We note statistically significant higher SMRs for every anatomic cancer site in nonblack men and women and for most cancer sites in black men and women.

MedicalResearch.com eInterview: Professor Nigel S. Scrutton ScD FRSC FSB Director Manchester Institute of Biotechnology EPSRC Established Career Fellow |Faculty of Life Sciences | Manchester Institute of Biotechnology | University of Manchester | Manchester | M1 7DN | UK | MedicalResearch.com: What are the main findings of your study? Dr. Scrutton: A major breakthrough has been made by our team of researchers seeking treatments for degenerative illnesses such as Parkinson's Disease. We have detailed how an enzyme in the brain interacts with a drug-like lead compound directed against Huntington's Disease (but also with major implications for Alzheimer’s and Parkinson’s diseases) to inhibit its activity. The work – which solved the molecular structure of a crucial brain enzyme called kynurenine 3-monooxygenase – opens the door to effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. The main findings not only describe the molecular details of the enzyme, but also how it interacts with a lead drug compound that inhibits the natural activity of the enzyme.

Dr. Brian I. Labow MD Boston Children’s HospitalMedicalResearch.com eInterview with Dr. Brian I. Labow MD Boston Children’s Hospital Dr. Labow received his MD from Harvard Medical School. He completed his postgraduate training at Massachusetts General Hospital, Harvard Plastic Surgery Training Program, Children's Hospital Boston, and Beth Israel Deaconess Medical Center. MedicalResearch.com: What are the main findings of the study? Dr. Labow: The main finding of the study is that gynecomastia, the enlargement of breast tissue in men, can have a significant impact on the psychosocial wellbeing of adolescent patients.  Noted deficits were found in patients’ social functioning, mental health, and self-esteem when compared to healthy boys of the same age.  Validated surveys were given to both groups to assess a wide array of different health domains.  Interestingly there was no difference in the physical health of boys with gynecomastia and unaffected boys when differences in BMI were taken into consideration.

Karl K. Szpunar PhD Department of Psychology, Harvard University, Cambridge, MA 02138MedicalResearch.com Interview with Karl K. Szpunar PhD Department of Psychology, Harvard University, Cambridge, MA 02138 MedicalResearch.com:   What are the main findings of the study? Dr. Szpunar: The results of our experiments demonstrate that students can have difficulty paying attention to online lectures, and that including brief quizzes during lectures can help to alleviate this problem. Specifically, we found that students who were tested throughout a 21-minute long Statistics lecture were half as likely to mind wander during the lecture, three times as likely to take additional notes, and much better able to retain the contents of the lecture at a later time.

MedicalResearch.com Interview with Mylin A. Torres, M.D. Assistant Professor Department of Radiation Oncology Emory University School of Medicine Atlanta, GA 30322 MedicalResearch.com: What are the main findings of the study?  Dr. Torres: Radiation treatment for breast cancer is not associated with increased depressive symptoms, but of disease and treatment-related factors, prior chemotherapy treatment is a significant predictor of depression before and after radiation treatment.  Prior chemotherapy treatment was associated with inflammatory mediators, including nuclear factor-kappa B DNA binding, soluble tumor necrosis factor-alpha receptor 2, and interleukin-6, which predicted for depressive symptoms after radiation on univariate analysis.

Laura B. Zahodne, PhD Postdoctoral fellow in the cognitive neuroscience division in the Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain Columbia University Medical Center.MedicalResearch.com Interview with: Laura B. Zahodne, PhD Postdoctoral fellow in the cognitive neuroscience division in the Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain Columbia University Medical Center. MedicalResearch.com: What are the main findings of the study? Dr. Zahodne: Having more depressive symptoms early on in Alzheimer’s disease was associated with more rapid declines in the ability to handle tasks of everyday living, and this relationship was independent of cognitive decline. MedicalResearch.com: Were any of the findings unexpected? Dr. Zahodne: Previous studies have shown that depressive symptoms are associated with more difficulties with thinking and daily activities. This study additionally shows that depressive symptoms herald not only more rapid declines in thinking, but also daily functioning, over time.

 Dr. Anna Nordström MD Department of Community Medicine and Rehabilitation, Rehabilitation Medicine, Umeå University, SE-901 87 Umeå, SwedenMedical Research.com Interview with Dr. Anna Nordström MD Department of Community Medicine and Rehabilitation, Rehabilitation Medicine, Umeå University, SE-901 87 Umeå, Sweden Medical Research.com: What are the main findings of the study? Dr. Nordström: We have found that low cognitive function and factors related to low socioeconomic status and intoxications are strong independent risk factors for mild traumatic brain injury in men. Medical Research.com: Were any of the findings unexpected? Dr. Nordström:  Our knowledge of risk factors that predispose people to sustaining such injury is limited. Previous research has inferred that mild traumatic brain injuries have important long-term consequences on cognitive function. However, we found similar deficits in cognitive function in subjects that sustained a mild traumatic brain injury before and after cognitive testing. Thus our data suggest that the injury itself may not reduce cognitive function.

Alzheimer's plaques in PET brain scans identify future cognitive decline DURHAM, N.C. – Among patients with mild or no cognitive impairment, brain scans using a new radioactive dye can detect early evidence of Alzheimer's disease that may predict future decline, according to a multi-center study led by researchers at Duke University...

Release Date: 10/03/2011 Johns Hopkins-led research suggests levels of certain fats in blood might predict rate of cognitive decline. A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer’s disease (AD) will lose cognitive function by looking at ratios...

Knowledge about the biological origin of diseases like schizophrenia, bipolar disorder and other psychiatric conditions is critical to improving diagnosis and treatment. In an effort to push the field forward, three UCLA researchers, along with scientists from more than 20 countries, have been taking part in one of the largest collaborative...

PITTSBURGH—Autism is a mysterious developmental disease because it often leaves complex abilities intact while impairing seemingly elementary ones. For example, it is well documented that autistic children often have difficulty correctly using pronouns, sometimes referring to themselves as "you" instead of "I." A new brain imaging study published in the journal...

Reston, Va.–Two new studies published in the August issue of The Journal of Nuclear Medicine (JNM) provide insight intothe potential of positron emission tomography (PET) to differentiate between types of dementia and to identify pharmaceuticals to slow the progress of dementia. With proposed National Institute on Aging (NIA) and the...

American Stroke Association Scientific Statement Statement Highlights: • High blood pressure is related to the development of age-related vascular cognitive impairment. • Maintaining a healthy heart may also maintain a healthy functioning brain, according to the statement. • Screening elderly patients for heart and stroke risk factors may also identify those at risk of...